Vanguard Investments Australia
BSX icon

Vanguard Investments Australia’s Boston Scientific BSX Stock Holding History

Vanguard Investments Australia’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.4M Buy
760,113
+22,370
+3% +$1.21M 0.08% 227
2026
Q1 		$46.3M Buy
+737,743
New +$59M 0.13% 141

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Investments Australia's BSX Position: Q2 2026 in Review

Vanguard Investments Australia increased its Boston Scientific (BSX) stake by 3% in Q2 2026, buying an estimated $1.21M and bringing the position to 760,113 shares worth $32.4M. The position accounts for 0.08% of the portfolio, ranked #227.

Vanguard Investments Australia first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $46.3M in Q1 2026. 1,381 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Vanguard Investments Australia held 760,113 shares of Boston Scientific worth $32.4M as of Q2 2026.
  • Vanguard Investments Australia bought 22,370 Boston Scientific shares in Q2 2026, an estimated $1.21M.
  • Boston Scientific made up 0.08% of Vanguard Investments Australia's portfolio in Q2 2026, its #227 holding.
  • Vanguard Investments Australia first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Investments Australia's Boston Scientific position peaked at $46.3M in Q1 2026.
  • 1,381 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.